174 related articles for article (PubMed ID: 12922927)
1. Pharmacological characterization of prostanoid receptors mediating vasoconstriction in human umbilical vein.
Daray FM; Minvielle AI; Puppo S; Rothlin RP
Br J Pharmacol; 2003 Aug; 139(8):1409-16. PubMed ID: 12922927
[TBL] [Abstract][Full Text] [Related]
2. Prostanoid EP(1)- and TP-receptors involved in the contraction of human pulmonary veins.
Walch L; de Montpreville V; Brink C; Norel X
Br J Pharmacol; 2001 Dec; 134(8):1671-8. PubMed ID: 11739243
[TBL] [Abstract][Full Text] [Related]
3. Characterization of prostanoid receptors mediating actions of the isoprostanes, 8-iso-PGE(2) and 8-iso-PGF(2alpha), in some isolated smooth muscle preparations.
Sametz W; Hennerbichler S; Glaser S; Wintersteiger R; Juan H
Br J Pharmacol; 2000 Aug; 130(8):1903-10. PubMed ID: 10952681
[TBL] [Abstract][Full Text] [Related]
4. Potentiation of adrenaline vasoconstrictor response by sub-threshold concentrations of U-46619 in human umbilical vein: involvement of smooth muscle prostanoid TP(alpha) receptor isoform.
Errasti AE; Luciani LI; Cesio CE; Tramontano J; Boveris D; Daray FM; Nowak W; Pelorosso FG; Rothlin RP
Eur J Pharmacol; 2007 May; 562(3):227-35. PubMed ID: 17362923
[TBL] [Abstract][Full Text] [Related]
5. Involvement of TP and EP3 receptors in vasoconstrictor responses to isoprostanes in pulmonary vasculature.
Janssen LJ; Tazzeo T
J Pharmacol Exp Ther; 2002 Jun; 301(3):1060-6. PubMed ID: 12023538
[TBL] [Abstract][Full Text] [Related]
6. EP4 prostanoid receptor-mediated vasodilatation of human middle cerebral arteries.
Davis RJ; Murdoch CE; Ali M; Purbrick S; Ravid R; Baxter GS; Tilford N; Sheldrick RL; Clark KL; Coleman RA
Br J Pharmacol; 2004 Feb; 141(4):580-5. PubMed ID: 14744815
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
Meja KK; Barnes PJ; Giembycz MA
Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterization of thromboxane and prostanoid receptors in human isolated urinary bladder.
Palea S; Toson G; Pietra C; Trist DG; Artibani W; Romano O; Corsi M
Br J Pharmacol; 1998 Jul; 124(5):865-72. PubMed ID: 9692770
[TBL] [Abstract][Full Text] [Related]
9. Vasoconstrictor effects of 8-iso-prostaglandin E2 and 8-iso-prostaglandin F(2alpha) on human umbilical vein.
Daray FM; Minvielle AI; Puppo S; Rothlin RP
Eur J Pharmacol; 2004 Sep; 499(1-2):189-95. PubMed ID: 15363966
[TBL] [Abstract][Full Text] [Related]
10. Expression and functional evidence of the prostaglandin F2alpha receptor mediating contraction in human umbilical vein.
Errasti AE; del-Rey G; Cesio CE; Souza G; Nowak W; Pelorosso FG; Daray FM; Rothlin RP
Eur J Pharmacol; 2009 May; 610(1-3):68-74. PubMed ID: 19289115
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the human prostanoid TPalpha and TPbeta receptor isoforms mediated through activation of the EP(1) and IP receptors.
Walsh MT; Kinsella BT
Br J Pharmacol; 2000 Oct; 131(3):601-9. PubMed ID: 11015313
[TBL] [Abstract][Full Text] [Related]
12. Differential peristaltic motor effects of prostanoid (DP, EP, IP, TP) and leukotriene receptor agonists in the guinea-pig isolated small intestine.
Shahbazian A; Heinemann A; Peskar BA; Holzer P
Br J Pharmacol; 2002 Dec; 137(7):1047-54. PubMed ID: 12429577
[TBL] [Abstract][Full Text] [Related]
13. Characterization of excitatory prostanoid receptors in the human umbilical artery in vitro.
Boersma JI; Janzen KM; Oliveira L; Crankshaw DJ
Br J Pharmacol; 1999 Dec; 128(7):1505-12. PubMed ID: 10602330
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E2 inhibits mast cell-dependent bronchoconstriction in human small airways through the E prostanoid subtype 2 receptor.
Säfholm J; Manson ML; Bood J; Delin I; Orre AC; Bergman P; Al-Ameri M; Dahlén SE; Adner M
J Allergy Clin Immunol; 2015 Nov; 136(5):1232-9.e1. PubMed ID: 25962903
[TBL] [Abstract][Full Text] [Related]
15. Prostanoid receptors involved in regulation of the beating rate of neonatal rat cardiomyocytes.
Mechiche H; Grassin-Delyle S; Robinet A; Nazeyrollas P; Devillier P
PLoS One; 2012; 7(9):e45273. PubMed ID: 22984630
[TBL] [Abstract][Full Text] [Related]
16. Identification in human airways smooth muscle cells of the prostanoid receptor and signalling pathway through which PGE2 inhibits the release of GM-CSF.
Clarke DL; Belvisi MG; Catley MC; Yacoub MH; Newton R; Giembycz MA
Br J Pharmacol; 2004 Apr; 141(7):1141-50. PubMed ID: 15023863
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the prostanoid receptors mediating constriction and relaxation of human isolated uterine artery.
Baxter GS; Clayton JK; Coleman RA; Marshall K; Sangha R; Senior J
Br J Pharmacol; 1995 Sep; 116(1):1692-6. PubMed ID: 8564239
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E2 suppression of acetylcholine release from parasympathetic nerves innervating guinea-pig trachea by interacting with prostanoid receptors of the EP3-subtype.
Spicuzza L; Giembycz MA; Barnes PJ; Belvisi MG
Br J Pharmacol; 1998 Mar; 123(6):1246-52. PubMed ID: 9559911
[TBL] [Abstract][Full Text] [Related]
19. The role of prostaglandin E and thromboxane-prostanoid receptors in the response to prostaglandin E2 in the aorta of Wistar Kyoto rats and spontaneously hypertensive rats.
Tang EH; Jensen BL; Skott O; Leung GP; Feletou M; Man RY; Vanhoutte PM
Cardiovasc Res; 2008 Apr; 78(1):130-8. PubMed ID: 18093985
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization of muscarinic receptor subtypes mediating vasoconstriction of human umbilical vein.
Pujol Lereis VA; Hita FJ; Gobbi MD; Verdi MG; Rodriguez MC; Rothlin RP
Br J Pharmacol; 2006 Mar; 147(5):516-23. PubMed ID: 16444291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
